Ceru Quarterly Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Preliminary Fourth Quarter and Full-Year 2023 Product Revenues of $46.8 million and $156.4 million, respectively 2024 Product Revenues expected to be between $172-$175 million, reflecting 10%-12%.

United statesCerus corporationCerus corporation nasdaqExchange commissionBlood cellLooking statementsPreliminary product revenueBiologics license applicationsCeru quarterly report

Cerus Corporation Announces Second Quarter 2023 Financial Results

Cerus Corporation Announces Second Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJessica hanoverNet loss attributable to cerus corporationCerus corporationExchange commissionWhile the companyCorporate affairsCerus corporation nasdaqUs department of defenseCerus zhongbaokang shandong biomedical coBlood cellsDutch medicines evaluation boardDevice regulationBlood cellRed blood cellsLoss attributable

Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results

Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoel trujilloExchange commissionCerus zhongbaokang shandong biomedical coCerus corporationNet loss attributable to cerus corporationCerus corporation nasdaqWall streetRevenue growth drivenRevenue guidance rangeRed blood cellsBlood cellLoss attributableInvestor relationsBiologics license applicationsCeru quarterly report

Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets

Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets - read this article along with other careers information, tips and advice on BioSpace

United statesGrahamd sherChristian boutemyExchange commissionCerus corporationCanadian blood serviceCerus corporation nasdaqHealth canadaCanadian blood servicesBlood servicesCeru quarterly reportErus corporation announces contract with canadian blood services for intercept system plateletsஒன்றுபட்டது மாநிலங்களில்பரிமாற்றம் தரகுகனடியன் இரத்தம் சேவைஆரோக்கியம் கனடா